3002.51.00.00/Dendritic Cell Vaccine for Prostate Cancer/Mexico

Dendritic Cell Vaccine for Prostate Cancer from Mexico

Autologous dendritic cells loaded with tumor-associated antigens (e.g., Provenge/sipuleucel-T), matured ex vivo for personalized cancer vaccination. HTS 3002.51.00.00 applies to these as cell therapy products—modified cell cultures for active immunotherapy. They prime T-cell responses against prostate cancer cells.

Duty Rate — Mexico → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Include antigen pulsing validation and DC maturation markers in shipment docs

• Patient-specific labeling required—match lot to clinical records

Dendritic Cell Vaccine for Prostate Cancer from Mexico — Import Duty Rate | HTS 3002.51.00.00